Biotechnology

Defra Publishes Precision-Bred Tomato Release Notice (PBR/26/005) for England

Defra has published a schedule 1 notice for a CRISPR-edited tomato plant, allowing its first precision-bred field release in England from late May 2026 under the UK’s precision breeding regulations. This marks further operational use of the precision breeding regime for plant trials, signalling potential future applications but creating no new obligations beyond the notifier’s duty to avoid marketing before confirmation.

13 May 2026, 12:38gov.ukUnited Kingdom

EU Commission Renews Authorisation for GM Cotton T304-40 Under Regulation 1829/2003

In March 2026 the European Commission renewed, for a further ten years, the EU authorisation to place on the market food, feed and other products containing or produced from genetically modified cotton T304-40 under the GM food and feed framework. This maintains existing GM cotton T304-40 supply chains into the EU but keeps strict traceability, labelling (including “not for cultivation”) and environmental monitoring obligations in place for agri-food and feed businesses using these products.

12 May 2026, 18:26eur-lex.europa.euEuropean Union

UK DEFRA Consults on Wild Bioscience GMO Release Application 26/R55/01

Defra has opened a consultation on Wild Bioscience Ltd’s application to deliberately release genetically modified wheat in the UK (reference 26/R55/01), with responses due by 27 June 2026. The outcome will shape expectations for environmental risk assessment and stakeholder scrutiny of future GMO field releases in UK agriculture.

12 May 2026, 15:39gov.ukUnited Kingdom

European Commission Clarifies Equivalence And Labelling For Category 1 NGT Plants

In May 2026 the European Commission answered an MEP question by confirming the scientific basis and regulatory safeguards for treating certain “category 1” plants obtained by new genomic techniques as equivalent to conventional plants under the draft NGT regulation. For companies in seeds, crops, and food and feed, this clarifies that these NGT varieties would be exempt from additional GMO risk assessment but remain subject to conventional‑plant rules, a monitoring programme, and public register and seed‑labelling transparency, informing how they design future breeding and segregation strategies.

12 May 2026, 15:10europarl.europa.euEuropean Union

UK DEFRA Invites Representations On Gene-Edited Wheat Field Trial Application From Wild Bioscience Ltd (Ref 26/R55/01)

In May 2026 the UK Department for Environment, Food & Rural Affairs opened consultation on Wild Bioscience Ltd’s application to conduct multi-site field trials of gene-edited wheat (reference 26/R55/01), inviting public representations on potential environmental risks by 27 June 2026. This development signals continued expansion of UK GMO field research under existing Environmental Protection Act and GMO deliberate release rules, and stakeholders should assess implications for crop innovation, coexistence, and future commercial approvals during the consultation window.

12 May 2026, 15:08gov.ukUnited Kingdom

EU Council Presidency Issues Second Compromise Text on Amendments to GMO and Organ Transplant Directives

Council negotiators have issued a second presidency compromise text on an EU directive revising the GMO Deliberate Release Directive and the Organs Directive to address placing genetically modified micro-organisms on the market and organ processing. If adopted, this biotech-focused reform will reshape approval and oversight frameworks for GMM-based products and organ processing in the EU, so stakeholders in biotechnology, healthcare and transplant services should track how the final text defines scope, risk controls and compliance timelines.

11 May 2026, 12:00eur-lex.europa.euEuropean Union

China National Health Commission Consults on Draft Implementing Rules for Human Genetic Resources Management Regulation

China's National Health Commission has issued draft implementing rules for the Regulation on the Administration of Human Genetic Resources and launched a public consultation running to 7 June 2026. The proposal would centralise human genetic resource oversight under NHC and tighten licensing, biobanking, international cooperation, export and data-sharing requirements, requiring hospitals, research institutions and life-science firms to reassess governance, approvals and cross-border processes.

9 May 2026, 19:07nhc.gov.cnChina

EU Parliament ENVI Amendments To Second-Reading Recommendation On New Genomic Techniques Regulation For Plants And Food/Feed

In May 2026, the European Parliament’s environment committee tabled 37 amendments to its second-reading recommendation on the proposed EU regulation for plants obtained by certain new genomic techniques and their food and feed, which would also amend the Official Controls Regulation. These amendments press for stricter rules on patentability, traceability, labelling and safeguards for NGT plants, signalling potential last-minute changes to compliance expectations for seed, farming and food operators before the regulation is finalised.

9 May 2026, 19:03europarl.europa.euEuropean Union

EU PAFF GM Food and Feed Committee Advances GM Crop Files and Backs Ending Five GM Cotton Renewals

At its 27 April 2026 meeting, the EU PAFF GM Food and Feed Committee recorded no-opinion votes on three draft Commission Implementing Decisions for GM maize and soybean events, gave a favourable opinion on terminating renewal procedures for five GM cotton authorisations at the applicant’s request, and noted EFSA’s now positive risk assessment for GM oilseed rape MS11. These outcomes move key GM crop authorisation and renewal files into the Appeal Committee phase and signal that certain cotton events are likely to exit the active EU authorisation framework, increasing the importance of tracking forthcoming Commission decisions and planning for potential changes in product portfolios, labelling and sourcing.

9 May 2026, 14:22food.ec.europa.euEuropean Union

EP Public Health Committee Opinion on the European Competitiveness Fund (ECF) Proposal

In May 2026 the European Parliament’s Public Health Committee adopted an opinion on the proposed European Competitiveness Fund that seeks ring-fenced investment in health, biotechnology, biodefence and digital health infrastructure, with dedicated envelopes for prevention, preparedness, health innovation and health-sector SMEs. If reflected in the final regulation, this would channel substantial EU funding towards resilient pharmaceutical and medical supply chains (including APIs, vaccines and antimicrobials), advanced biotech and digital health capabilities, and pollution-related health protections, reshaping medium-term investment opportunities for health and biotech manufacturers.

9 May 2026, 13:25europarl.europa.euEuropean Union

EU Commission Adopts Implementing Regulation Authorising L-Tryptophan Produced With Escherichia coli CCTCC M 2024517 as Feed Additive for All Animal Species

In May 2026 the European Commission adopted an implementing regulation to authorise L-tryptophan produced with Escherichia coli CCTCC M 2024517 as a feed additive for all animal species in the EU. This adds another approved L-tryptophan source for feed manufacturers, with detailed purity, labelling and use conditions to follow in the Official Journal text, potentially broadening supplier options while maintaining safety controls.

9 May 2026, 07:15ec.europa.euEuropean Union

EU Publishes Expert Report on Regulation of Engineered Living Materials

In April 2026 the EU published an expert report for the European Innovation Council on how existing EU GMO, food and product-safety law applies to Engineered Living Materials and what regulatory options could govern their future market entry. The report warns that without clearer, faster and more predictable authorisation and liability frameworks, Europe risks underinvestment in ELM-based innovations, so regulators and investors should anticipate pressure for more harmonised guidance across health, construction and environmental applications.

8 May 2026, 09:15webgate.ec.europa.euEuropean Union

USDA Announces Online Guidance Portal for Agency Guidance Documents

In April 2026 USDA launched a centralised online Guidance Portal that consolidates currently effective guidance documents across all USDA agencies into a single searchable database. This signals that the portal is now the primary reference point for USDA interpretive materials, helping regulated businesses, including those in biotechnology, verify which guidance is operative and update internal compliance practices accordingly.

6 May 2026, 19:15usda.govUnited States

European Parliament Receives Council First-Reading Position on New Genomic Techniques Plants

On 30 April 2026, the European Parliament formally recorded receipt of the Council’s first‑reading position on the proposed EU regulation on plants obtained by certain new genomic techniques, triggering a three‑month period from 1 May 2026 for Parliament to adopt its own position. This fixes a clear decision-making window for the politically sensitive NGT file, helping plant breeders, agri‑food companies and other stakeholders anticipate when EU rules on placing NGT-derived plant varieties and their food and feed on the market are likely to be finalised.

6 May 2026, 07:27europarl.europa.euEuropean Union

EU Council Issues Statement of Reasons for Position (EU) No 6/2026 on Plants Obtained by Certain New Genomic Techniques

The EU Council has published in the Official Journal its statement of reasons for Position (EU) No 6/2026 on the proposed Regulation governing plants obtained by certain new genomic techniques and their products. This confirms a near-final political compromise that will shape how NGT crops are classified, authorised, labelled and used in EU agriculture and organics, with implications for plant breeders, seed suppliers and agri-food chains.

4 May 2026, 20:05eur-lex.europa.euEuropean Union

EU Council Publishes First-Reading Position on New Genomic Techniques Plants Regulation

The EU Council’s first-reading position on the New Genomic Techniques plants Regulation has now been published in the Official Journal, setting out the full future regime for NGT plants, their food and feed, and related amendments to the Official Controls Regulation. This text signals that a two-tier EU framework for NGT plants (category 1 vs 2), with organic exclusions, tailored GMO-style authorisation and sustainability incentives, is close to adoption, so breeders, seed companies and food operators should start mapping impacts on pipelines, labelling and GMO compliance strategies.

4 May 2026, 20:04eur-lex.europa.euEuropean Union

US GPO Publishes Bill Text Of Engineering Biology Readiness Act (S.4363)

The US Government Publishing Office has released the full text of Senate bill S.4363 Engineering Biology Readiness Act, which would extend annual National Biodefense Strategy briefings and require a comprehensive federal analysis of engineering biology risks. While still an early-stage proposal, it signals stronger US focus on biosafety and biosecurity governance for engineering biology, potentially informing future regulatory frameworks and expectations for life science and biomanufacturing organisations.

4 May 2026, 20:03govinfo.govUnited States

Taiwan TFDA Issues Guidance for Clinical Trial Applications of Human Extracellular Vesicle Products

In April 2026 Taiwan's TFDA issued guidance and standardised templates for sponsors applying to conduct clinical trials of human extracellular vesicle products. This clarifies expectations for EV trial documentation and processes in Taiwan, enabling companies developing these advanced biologics to align study design, submissions and reporting with regulator preferences.

3 May 2026, 14:42fda.gov.twTaiwan

Netherlands Issues GMO Environmental Permit IM 250019_001 to Prinses Máxima Centrum

The Netherlands has granted a GMO environmental permit to Prinses Máxima Centrum for ex vivo lentiviral modification of patient T-cells in a CNS cancer therapy trial, with documents available from early May 2026 and a six-week appeal window. This illustrates how the Dutch GMO environmental regime is being applied to advanced cell and gene therapies, signalling expectations for robust risk assessment, transparency, and public-law oversight in similar projects.

3 May 2026, 07:35zoek.officielebekendmakingen.nlNetherlands

US EPA Approves CarriCea T1 Citrus Rootstock to Combat Citrus Greening Disease

In April 2026 the US Environmental Protection Agency approved CarriCea T1, a gene-edited citrus rootstock registered as a plant-incorporated protectant to help trees resist citrus greening disease and reduce reliance on conventional pesticide sprays. This creates a new biotechnological pest management option under EPA’s pesticide framework, with implications for citrus growers’ pesticide programmes, supply security, and how plant-incorporated protectants are deployed alongside existing residue and tolerance decisions.

3 May 2026, 07:31content.govdelivery.comUnited States